At BPL, we are committed to providing a continuous supply of safe, reliable, high quality plasma-derived products worldwide, supporting both healthcare professionals and patients every day.
We are a UK headquartered company that delivers life-saving treatments for conditions related to immune deficiencies, bleeding disorders and critical care around the world. These treatments are produced from the complex transformation of plasma, which is collected from a number of US based collection facilities from US donors.
PRESS RELEASE - 6 June 2016: Bio Products Laboratory launches Coagadex® ▼ (human coagulation factor X) in the UK Treatment for rare bleeding disorder ‘hereditary factor X deficiency’ and is made available in the UK
ELSTREE, UK Bio Products Laboratory, Limited (BPL) today, announced that Coagadex...